Abe, K.; Watabe, T.; Kaneda-Nakashima, K.; Shirakami, Y.; Kadonaga, Y.; Naka, S.; Ooe, K.; Toyoshima, A.; Giesel, F.; Usui, T.;
et al. Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models. Int. J. Mol. Sci. 2024, 25, 11567.
https://doi.org/10.3390/ijms252111567
AMA Style
Abe K, Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Naka S, Ooe K, Toyoshima A, Giesel F, Usui T,
et al. Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models. International Journal of Molecular Sciences. 2024; 25(21):11567.
https://doi.org/10.3390/ijms252111567
Chicago/Turabian Style
Abe, Kaori, Tadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Sadahiro Naka, Kazuhiro Ooe, Atsushi Toyoshima, Frederik Giesel, Takeshi Usui,
and et al. 2024. "Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models" International Journal of Molecular Sciences 25, no. 21: 11567.
https://doi.org/10.3390/ijms252111567
APA Style
Abe, K., Watabe, T., Kaneda-Nakashima, K., Shirakami, Y., Kadonaga, Y., Naka, S., Ooe, K., Toyoshima, A., Giesel, F., Usui, T., Masunaga, N., Mishima, C., Tsukabe, M., Yoshinami, T., Sota, Y., Miyake, T., Tanei, T., Shimoda, M., & Shimazu, K.
(2024). Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models. International Journal of Molecular Sciences, 25(21), 11567.
https://doi.org/10.3390/ijms252111567